The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
A U.S. launch of the product is expected in just a few weeks.
By simplifying labeling compliance, companies can focus on better serving current and new markets.
Developing medical devices in general is costly, but there is funding available for companies that are willing to create products specifically for pediatrics.
Reparative medicine technology is an option to delay or avoid orthopedic surgery.
Despite the growth, total knee replacements are declining in average selling price.
The agency says there’s not enough evidence to demonstrate that there’s reasonable assurance of safety and effectiveness.
Storing gasoline next to orthopedic trays and instrument trays just isn’t a good idea.
Manufacturers that make custom devices must move beyond conventional engineering practices to an automated and collaborative engineer-to-order process.